Inventor · disambiguated record
Weiguang Mao
Also filed as: MAO WEIGUANG
6 granted patents·5 pending applications·1,064 citations·filing 2005–2019
85Inventor score
Top patents by PatentIndex Score
11 records- 0197US7527791B2Humanized anti-TGF-beta antibodiesGENENTECH INC·Filed 2005·Granted May 5, 2009·1k cites·26 claims
- 0292US7767205B2Anti-EphB2 antibodies and methods using sameGENENTECH INC·Filed 2007·Granted Aug 3, 2010·17 cites·18 claims
- 0389US8937161B2Cysteine engineered anti-TENB2 antibodies and antibody drug conjugatesMAO WEIGUANG·Filed 2008·Granted Jan 20, 2015·23 cites·37 claims
- 0488US8012482B2Humanized anti-TGF-beta antibodiesGENENTECH INC·Filed 2009·Granted Sep 6, 2011·11 cites·26 claims
- 0582US9175089B2Anti-LGR5 antibodies and immunoconjugatesGENENTECH INC·Filed 2013·Granted Nov 3, 2015·5 cites·31 claims
- 0659US2015158952A1Cysteine engineered anti-tenb2 antibodies and antibody drug conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 0757US2019248889A1Anti-lgr5 antibodies and uses thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 0856US10316084B2Anti-LGR5 antibodies and uses thereofGENENTECH INC·Filed 2016·Granted Jun 11, 2019·0 cites·33 claims
- 0952US2010278842A1Anti-ephb2 antibodies and methods using sameGENENTECH INC·Filed 2010·Application pending·0 cites
- 1051US2017166635A1Cysteine engineered anti-tenb2 antibodies and antibody drug conjugatesGENENTECH INC·Filed 2016·Application pending·0 cites
- 1142US2016102146A1Anti-lgr5 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →